This page provides contact information for US media. The GSK media team only responds to calls and emails from professional journalists. If you have a general or product-specific inquiry, refer to the contact details supplied on our customers/patients page.
US Media Team
We are committed to responding to the information needs of the media as quickly as possible. Please review the list of US media team members below and select the contact whose area of responsibility best fits your needs.
Kristen Neese, VP, Global Product & Pipeline Communications & US Corporate Communications
Kristen leads corporate communications in the US, and product and pipeline communications globally.
Kathleen Quinn, Head, US Corporate Communications
Mobile: +1 202-603-5003
Kathleen leads the US Corporate Communications team.
Evan Berland, Director, US Corporate Communications
Topics: Respiratory, vaccines (including COVID), global public health and litigation
Mobile: +1 215-432-0234
Lyndsay Meyer, Director, US Corporate Communications
Topics: Policy, access, and pricing; specialty (immunology - includes COVID Tx) and oncology
Mobile: +1 202-302-4595
Sydney Dodson-Nease, Manager, US Corporate Communications
Topics: D&I, US community partnerships, metrics
Kathleen Beatty, Director, GSK Consumer Healthcare
Topics: Consumer health products
Audrey Abernathy, Head of US Communications, ViiV Healthcare
Topics: ViiV healthcare products
Media Contacts for inquiries outside of the US
For press contacts at our Global Headquarters or in our local operating companies, please visit our country websites.
General media inquiries
If you have a general media inquiry, want to request access to our video footage library or receive our press releases, please contact the global media relations team at email@example.com. Please note this inbox is managed out of our global headquarters in the UK.
More media resources
Keep up to date with our news and recent announcements
We use social media as part of our commitment to transparency and to provide timely information to our customers and stakeholders
This information is intended for healthcare journalists, analysts and investors.
COVID-19 response and updates
GSK is closely monitoring the COVID-19 pandemic and is supporting global efforts to tackle the virus.